Inflammatix: Kian Beyzavi

Inflammatix has appointed Kian Beyzavi as an independent member of its board of directors. Beyzavi started her career at management consulting firm McKinsey and has more than 25 years of experience as a venture investor, entrepreneur, consultant, and general manager at Rho Ventures, Cubit Software, Medtronic, Abbott Diabetes Care, and Novartis Diagnostics.

For the past 10 years, she led a specialized consulting firm advising Fortune 500 companies, startups, and others about strategy, product development, business model innovation, commercialization, and monetization of opportunities across life sciences. Beyzavi is a venture partner at multistage investment firm Cota Capital.